^ elokdah h, abou-gharbia m, hennan jk, mcfarlane g, mugford cp, krishnamurthy g, crandall dl (july 2004). tiplaxtinin, novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, , preclinical characterization . journal of medicinal chemistry. 47 (14): 3491–4. doi:10.1021/jm049766q. pmid 15214776.
^ pautus s, alami m, adam f, bernadat g, lawrence da, de carvalho a, ferry g, rupin a, hamze a, champy p, bonneau n, gloanec p, peglion jl, brion jd, bianchini ep, borgel d (2016). characterization of annonaceous acetogenin, annonacinone, natural product inhibitor of plasminogen activator inhibitor-1 . scientific reports. 6: 36462. doi:10.1038/srep36462. pmc 5120274 . pmid 27876785.
Comments
Post a Comment